Diubiquitin (Ubd) is a susceptibility gene for virus-triggered autoimmune diabetes in rats

Genes and Immunity

Volumn 15, Issue 3, 2014, Pages 168-175

  Cort, L ^a   Habib, M ^b   Eberwine, R A ^a   Hessner, M J ^c   Mordes, J P ^b   Blankenhorn, E P ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

autoimmune diabetes; rat model; susceptibility genes; virus induced

Indexed keywords

DIUBIQUITIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYINOSINIC POLYCYTIDYLIC ACID; UBIQUITIN; UNCLASSIFIED DRUG; ZINC FINGER NUCLEASE; FAT10 PROTEIN, RAT;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE LOCUS; GENE MAPPING; GENETIC LINKAGE; GENETIC SUSCEPTIBILITY; HAPLOTYPE; HUMAN CHROMOSOME; IDDM37 GENE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL; PROMOTER REGION; RAT; UBD GENE; VIRUS INFECTION; ANIMAL; DISEASE MODEL; DISEASE PREDISPOSITION; GENE EXPRESSION; GENETIC COMPLEMENTATION; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; KNOCKOUT MOUSE; MORTALITY; PARVOVIRINAE; SINGLE NUCLEOTIDE POLYMORPHISM; VIROLOGY;

PARVOVIRUS; RATTUS;

ALLELES; ANIMALS; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC COMPLEMENTATION TEST; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; MICE, KNOCKOUT; PARVOVIRINAE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RATS; UBIQUITINS;

EID: 84899585787     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2013.72     Document Type: Article

References (57)

1. van Belle TL, Coppieters KT, von Herrath MG. Type 1 diabetes: etiology, immunology, and therapeutic strategies. Physiol Rev 2011; 91: 79-118.
2. Polychronakos C, Li Q. Understanding type 1 diabetes through genetics: advances and prospects. Nat Rev Genet 2011; 12: 781-792.
3. Trucco M. Gene-environment interaction in type 1 diabetes mellitus. Endocrinol Nutr 2009; 56(suppl 4): 56-59.
4. Concannon P, Rich SS, Nepom GT. Genetics of type 1A diabetes. N Engl J Med 2009; 360: 1646-1654.
5. Winkler C, Krumsiek J, Lempainen J, Achenbach P, Grallert H, Giannopoulou E et al. A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes. Genes Immun 2012; 13: 549-555.
6. Butter F, Davison L, Viturawong T, Scheibe M, Vermeulen M, Todd JA et al. Proteome-wide analysis of disease-associated SNPs that show allele-specific transcription factor binding. PLoS Genet 2012; 8: e1002982.
7. Bach JF. The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002; 347: 911-920.
8. Ghazarian L, Diana J, Simoni Y, Beaudoin L, Lehuen A. Prevention or acceleration of type 1 diabetes by viruses. Cell Mol Life Sci 2013; 70: 239-255.
9. Oikarinen S, Martiskainen M, Tauriainen S, Huhtala H, Ilonen J, Veijola R et al. Enterovirus RNA in blood is linked to the development of type 1 diabetes. Diabetes 2011; 60: 276-279.
10. Stene LC, Oikarinen S, Hyoty H, Barriga KJ, Norris JM, Klingensmith G et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 2010; 59: 3174-3180.
11. Richardson SJ, Willcox A, Bone AJ, Foulis AK, Morgan NG. The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 2009; 52: 1143-1151.
12. Roychoudhuri R, Hirahara K, Mousavi K, Clever D, Klebanoff CA, Bonelli M et al. BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature 2013; 498: 506-510.
13. D'Alise AM, Ergun A, Hill JA, Mathis D, Benoist C. A cluster of coregulated genes determines TGF-beta-induced regulatory T-cell (Treg) dysfunction in NOD mice. Proc Natl Acad Sci USA 2011; 108: 8737-8742.
14. Zhang L, Gianani R, Nakayama M, Liu E, Kobayashi M, Baschal E et al. Type 1 diabetes: chronic progressive autoimmune disease. Novartis Found Symp 2008; 292: 85-94, discussion 94-8, 122-9, 202-3.
15. Baschal EE, Aly TA, Jasinski JM, Steck AK, Johnson KN, Noble JA et al. The frequent and conserved DR3-B8-A1 extended haplotype confers less diabetes risk than other DR3 haplotypes. Diabetes Obes Metab 2009; 11: 25-30.
16. Aumeunier A, Grela F, Ramadan A, Pham Van L, Bardel E, Gomez Alcala A et al. Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS One 2010; 5: e11484.
17. Mordes J, Poussier P, Rossini AA, Blankenhorn EP, Greiner DL. Rat models of type 1 diabetes: Genetics, environment, and autoimmunity. In: Shafrir E (ed.). Animal Models of Diabetes: Frontiers in Research. CRC Press: Boca Raton, FL, USA, 2007.
18. Mordes J, Serreze DV, Greiner DL, Rossini AA. 'Animal models of autoimmune diabetes mellitus'. In: LeRoith D, Taylor SI, Olefsky JM (eds). Diabetes Mellitus. A Fundamental and Clinical Text. Lippincott Williams and Wilkins: NY, USA, 2004 591-610.
19. Chase HP, Butler-Simon N, Garg SK, Hayward A, Klingensmith GJ, Hamman RF et al. Cyclosporine A for the treatment of new-onset insulin-dependent diabetes mellitus. Pediatrics 1990; 85: 241-245.
20. Parving HH, Tarnow L, Nielsen FS, Rossing P, Mandrup-Poulsen T, Osterby R et al. Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study. Diabetes Care 1999; 22: 478-483.
21. Wherrett DK, Daneman D. Prevention of type 1 diabetes. Pediatr Clin North Am 2011; 58: 1257-1270, xi.
22. Mordes JP, Bortell R, Blankenhorn EP, Rossini AA, Greiner DL. Rat models of type 1 diabetes: genetics, environment, and autoimmunity. ILAR J 2004; 45: 278-291.
23. Mordes JP, Guberski DL, Leif JH, Woda BA, Flanagan JF, Greiner DL et al. LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation. Diabetes 2005; 54: 2727-2733.
24. Ellerman KE, Like AA. Susceptibility to diabetes is widely distributed in normal class IIu haplotype rats. Diabetologia 2000; 43: 890-898.
25. Blankenhorn EP, Cort L, Greiner DL, Guberski DL, Mordes JP. Virus-induced autoimmune diabetes in the LEW.1WR1 rat requires Iddm14 and a genetic locus proximal to the major histocompatibility complex. Diabetes 2009; 58: 2930-2938.
26. Martin AM, Maxson MN, Leif J, Mordes JP, Greiner DL, Blankenhorn EP. Diabetesprone and diabetes-resistant BB rats share a common major diabetes susceptibility locus, iddm4: additional evidence for a 'universal autoimmunity locus' on rat chromosome 4. Diabetes 1999; 48: 2138-2144.
27. Martin AM, Blankenhorn EP, Maxson MN, Zhao M, Leif J, Mordes JP et al. Non-major histocompatibility complex-linked diabetes susceptibility loci on chromosomes 4 and 13 in a backcross of the DP-BB/Wor rat to the WF rat. Diabetes 1999; 48: 50-58.
28. Blankenhorn EP, Rodemich L, Martin-Fernandez C, Leif J, Greiner DL, Mordes JP. The rat diabetes susceptibility locus Iddm4 and at least one additional gene are required for autoimmune diabetes induced by viral infection. Diabetes 2005; 54: 1233-1237.
29. Deruytter N, Boulard O, Garchon HJ. Mapping non-class II H2-linked loci for type 1 diabetes in nonobese diabetic mice. Diabetes 2004; 53: 3323-3327.
30. Aly TA, Ide A, Jahromi MM, Barker JM, Fernando MS, Babu SR et al. Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci USA 2006; 103: 14074-14079.
31. Aly TA, Baschal EE, Jahromi MM, Fernando MS, Babu SR, Fingerlin TE et al. Analysis of single nucleotide polymorphisms identifies major type 1A diabetes locus telomeric of the major histocompatibility complex. Diabetes 2008; 57: 770-776.
32. Awata T, Guberski DL, Like AA. Genetics of the BB rat: association of autoimmune disorders (diabetes, insulitis, and thyroiditis) with lymphopenia and major histocompatibility complex class II. Endocrinology 1995; 136: 5731-5735.
33. Kohoutava M, Gunther E, Stark O. Genetic definition of a further gene region and identification of at least three different histocompatibility genes in the rat major histocompatibility system. Immunogenetics 1980; 11: 483-490.
34. Blankenhorn EP, Descipio C, Rodemich L, Cort L, Leif JH, Greiner DL et al. Refinement of the Iddm4 diabetes susceptibility locus reveals TCRVbeta4 as a candidate gene. Ann N Y Acad Sci 2007; 1103: 128-131.
35. Hipp MS, Kalveram B, Raasi S, Groettrup M, Schmidtke G. FAT10, a ubiquitinindependent signal for proteasomal degradation. Mol Cell Biol 2005; 25: 3483-3491.
36. Lukasiak S, Schiller C, Oehlschlaeger P, Schmidtke G, Krause P, Legler DF et al. Proinflammatory cytokines cause FAT10 upregulation in cancers of liver and colon. Oncogene 2008; 27: 6068-6074.
37. Atkinson MA, Leiter EH. The NOD mouse model of type 1 diabetes: as good as it gets? Nat Med 1999; 5: 601-604.
38. Geurts AM, Cost GJ, Freyvert Y, Zeitler B, Miller JC, Choi VM et al. Knockout rats via embryo microinjection of zinc-finger nucleases. Science 2009; 325: 433.
39. Geurts AM, Cost GJ, Remy S, Cui X, Tesson L, Usal C et al. Generation of gene-specific mutated rats using zinc-finger nucleases. Methods Mol Biol 2010; 597: 211-225.
40. Geurts AM, Moreno C. Zinc-finger nucleases: new strategies to target the rat genome. Clin Sci (Lond) 2010; 119: 303-311.
41. Jacob HJ, Lazar J, Dwinell MR, Moreno C, Geurts AM. Gene targeting in the rat: advances and opportunities. Trends Genet 2010; 26: 510-518.
42. Chernova T, Higginson FM, Davies R, Smith AG. B2 SINE retrotransposon causes polymorphic expression of mouse 5-aminolevulinic acid synthase 1 gene. Biochem Biophys Res Commun 2008; 377: 515-520.
43. Mariner PD, Walters RD, Espinoza CA, Drullinger LF, Wagner SD, Kugel JF et al. Human Alu RNA is a modular transacting repressor of mRNA transcription during heat shock. Mol Cell 2008; 29: 499-509.
44. Bates EE, Ravel O, Dieu MC, Ho S, Guret C, Bridon JM et al. Identification and analysis of a novel member of the ubiquitin family expressed in dendritic cells and mature B cells. Eur J Immunol 1997; 27: 2471-2477.
45. Canaan A, Yu X, Booth CJ, Lian J, Lazar I, Gamfi SL et al. FAT10/diubiquitin-like protein-deficient mice exhibit minimal phenotypic differences. Mol Cell Biol 2006; 26: 5180-5189.
46. Gong P, Canaan A, Wang B, Leventhal J, Snyder A, Nair V et al. The ubiquitin-like protein FAT10 mediates NF-kappaB activation. J Am Soc Nephrol 2010; 21: 316-326.
47. Ebstein F, Lange N, Urban S, Seifert U, Kruger E, Kloetzel PM. Maturation of human dendritic cells is accompanied by functional remodelling of the ubiquitinproteasome system. Int J Biochem Cell Biol 2009; 41: 1205-1215.
48. Ebstein F, Lehmann A, Kloetzel PM. The FAT10- and ubiquitin-dependent degradation machineries exhibit common and distinct requirements for MHC class I antigen presentation. Cell Mol Life Sci 2012; 69: 2443-2454.
49. Schmidtke G, Kalveram B, Groettrup M. Degradation of FAT10 by the 26S proteasome is independent of ubiquitylation but relies on NUB1L. FEBS Lett 2009; 583: 591-594.
50. Yokoi N, Komeda K, Wang HY, Yano H, Kitada K, Saitoh Y et al. Cblb is a major susceptibility gene for rat type 1 diabetes mellitus. Nat Genet 2002; 31: 391-394.
51. Yokoi N, Fujiwara Y, Wang HY, Kitao M, Hayashi C, Someya T et al. Identification and functional analysis of CBLB mutations in type 1 diabetes. Biochem Biophys Res Commun 2008; 368: 37-42.
52. Baschal EE, Sarkar SA, Boyle TA, Siebert JC, Jasinski JM, Grabek KR et al. Replication and further characterization of a Type 1 diabetes-associated locus at the telomeric end of the major histocompatibility complex. J Diabetes 2011; 3: 238-247.
53. Kohoutavá M, Günther E, Stark O. Genetic definition of a further gene region and identification of at least three different histocompatibility genes in the rat major histocompatibility system. Immunogenetics 1980; 11: 483-490.
54. Mordes JP, Leif J, Novak S, DeScipio C, Greiner DL, Blankenhorn EP. The iddm4 locus segregates with diabetes susceptibility in congenic WF.iddm4 rats. Diabetes 2002; 51: 3254-3262.
55. Institute of Laboratory Animal Research CoLS, National Research Council. Guide for the Care and Use of Laboratory Animals. The National Academies Press: Washington, DC, USA, 1996.
56. Mordes JP, Cort L, Norowski E, Leif J, Fuller JM, Lernmark A et al. Analysis of the rat Iddm14 diabetes susceptibility locus in multiple rat strains: identification of a susceptibility haplotype in the Tcrb-V locus. Mamm Genome 2009; 20: 162-169.
57. Hong F, Breitling R, McEntee CW, Wittner BS, Nemhauser JL, Chory J. RankProd: a bioconductor package for detecting differentially expressed genes in meta-analysis. Bioinformatics 2006; 22: 2825-2827.